Vault-13

Bruce & Co., Inc.

CHICAGO, IL · CIK 1358331 · 13F filing filed 2022-08-09

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$425.1m reported value -13.1% vs Q1 2022
33positions
72.3%in top 10
1 new 1 added 7 reduced 0 sold out vs Q1 2022

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 AMERCO COM UHAL UHAL 75,455 $36.1m8.49% 8.49% AddedShares held: Q3 2021 79.8k, Q4 2021 75.4k, Q1 2022 75.4k, Q2 2022 75.5k +100 +100 0.1%
2 FPL GROUP INC COM COM 460,000 $35.6m8.38% 8.38% ReducedShares held: Q3 2021 501.4k, Q4 2021 490.4k, Q1 2022 490.0k, Q2 2022 460.0k -30.0k -30,000 -6.1%
3 ABBVIE INC COM ABBV ABBV 223,500 $34.2m8.05% 8.05% ReducedShares held: Q3 2021 303.5k, Q4 2021 303.5k, Q1 2022 243.5k, Q2 2022 223.5k -20.0k -20,000 -8.2%
4 ALLSTATE CORP COM ALL ALL 269,300 $34.1m8.03% 8.03% ReducedShares held: Q3 2021 299.8k, Q4 2021 299.3k, Q1 2022 279.3k, Q2 2022 269.3k -10.0k -10,000 -3.6%
5 DUKE ENERGY CORP NEW COM NEW DUK DUK 286,200 $30.7m7.22% 7.22% UnchangedShares held: Q3 2021 286.2k, Q4 2021 286.2k, Q1 2022 286.2k, Q2 2022 286.2k
6 CMS ENERGY CORP COM CMS CMS 448,500 $30.3m7.12% 7.12% ReducedShares held: Q3 2021 468.5k, Q4 2021 468.5k, Q1 2022 468.5k, Q2 2022 448.5k -20.0k -20,000 -4.3%
7 Merck & Co Inc COM COM 323,700 $29.5m6.94% 6.94% UnchangedShares held: Q3 2021 323.7k, Q4 2021 323.7k, Q1 2022 323.7k, Q2 2022 323.7k
8 XCEL ENERGY INC COM XEL XEL 412,500 $29.2m6.87% 6.87% UnchangedShares held: Q3 2021 412.5k, Q4 2021 412.5k, Q1 2022 412.5k, Q2 2022 412.5k
9 PFIZER INC COM PFE PFE 542,700 $28.5m6.69% 6.69% UnchangedShares held: Q3 2021 544.7k, Q4 2021 543.7k, Q1 2022 542.7k, Q2 2022 542.7k
10 AT&T INC COM T T 922,000 $19.3m4.55% 4.55% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 922.0k, Q2 2022 922.0k
11 APPLE INC COM AAPL AAPL 137,400 $18.8m4.42% 4.42% UnchangedShares held: Q3 2021 242.7k, Q4 2021 167.4k, Q1 2022 137.4k, Q2 2022 137.4k
12 ABBOTT LABS COM ABT ABT 167,600 $18.2m4.28% 4.28% UnchangedShares held: Q3 2021 177.6k, Q4 2021 177.6k, Q1 2022 167.6k, Q2 2022 167.6k
13 Paratek CV 4.75% · principal CV 4.75% · principal 16,600,000 $14.3m3.36% 3.36% UnchangedPrincipal held: Q3 2021 16.6m, Q4 2021 16.6m, Q1 2022 16.6m, Q2 2022 16.6m
14 VALEANT PHARMACEUTICALS INTL COM COM 1,381,000 $11.5m2.71% 2.71% UnchangedShares held: Q3 2021 1.4m, Q4 2021 1.4m, Q1 2022 1.4m, Q2 2022 1.4m
15 AVISTA CORP COM AVA AVA 205,000 $8.9m2.10% 2.10% UnchangedShares held: Q3 2021 205.0k, Q4 2021 205.0k, Q1 2022 205.0k, Q2 2022 205.0k
16 SUPERNUS PHARMACEUTICALS INC COM SUPN SUPN 202,105 $5.8m1.37% 1.37% ReducedShares held: Q3 2021 402.1k, Q4 2021 402.1k, Q1 2022 222.1k, Q2 2022 202.1k -20.0k -20,000 -9.0%
17 GENERAL ELECTRIC CO COM COM 84,375 $5.4m1.26% 1.26% ReducedShares held: Q3 2021 104.4k, Q4 2021 104.4k, Q1 2022 104.4k, Q2 2022 84.4k -20.0k -20,000 -19.2%
18 SIRIUS XM HOLDINGS INC COM SIRI SIRI 757,843 $4.6m1.09% 1.09% UnchangedShares held: Q3 2021 857.8k, Q4 2021 857.8k, Q1 2022 757.8k, Q2 2022 757.8k
19 NEWMONT CORP COM NEM NEM 65,000 $3.9m0.91% 0.91% UnchangedShares held: Q3 2021 65.0k, Q4 2021 65.0k, Q1 2022 65.0k, Q2 2022 65.0k
20 EDAP TMS S A SPONSORED ADR FOCL FOCL 565,652 $3.8m0.90% 0.90% UnchangedShares held: Q3 2021 565.7k, Q4 2021 565.7k, Q1 2022 565.7k, Q2 2022 565.7k
21 Acorda Theraputics CV 6.0% · principal CV 6.0% · principal 5,000,000 $3.7m0.87% 0.87% UnchangedPrincipal held: Q3 2021 5.0m, Q4 2021 5.0m, Q1 2022 5.0m, Q2 2022 5.0m
22 PARATEK PHARMACEUTICALS INC COM PRTK PRTK 1,557,312 $3.0m0.71% 0.71% UnchangedShares held: Q3 2021 1.3m, Q4 2021 1.4m, Q1 2022 1.6m, Q2 2022 1.6m
23 WARNER BROS DISCOVERY INC COM SER A WBD WBD 222,558 $3.0m0.70% 0.70% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 222.6k
24 ASHLAND INC NEW COM COM 25,000 $2.6m0.61% 0.61% UnchangedShares held: Q3 2021 25.0k, Q4 2021 25.0k, Q1 2022 25.0k, Q2 2022 25.0k
25 AMRYT PHARMA PLC SPONSORED ADS SPONSORED ADS 315,182 $2.2m0.52% 0.52% UnchangedShares held: Q3 2021 407.4k, Q4 2021 315.2k, Q1 2022 315.2k, Q2 2022 315.2k
26 ACCELERATE DIAGNOSTICS INC NOTE 2.500% 3/1 · principal AXDX 2.5 03.15.23 · principal AXDX 2.5 03.15.23 3,000,000 $2.0m0.48% 0.48% UnchangedPrincipal held: Q3 2021 0, Q4 2021 0, Q1 2022 3.0m, Q2 2022 3.0m
27 FATE THERAPEUTICS INC COM FATE FATE 57,000 $1.4m0.33% 0.33% UnchangedShares held: Q3 2021 57.0k, Q4 2021 57.0k, Q1 2022 57.0k, Q2 2022 57.0k
28 ORGANON & CO COMMON STOCK OGN OGN 31,970 $1.1m0.25% 0.25% UnchangedShares held: Q3 2021 32.4k, Q4 2021 32.4k, Q1 2022 32.0k, Q2 2022 32.0k
29 IGM BIOSCIENCES INC COM IGMS IGMS 55,000 $991.0k0.23% 0.23% UnchangedShares held: Q3 2021 55.0k, Q4 2021 55.0k, Q1 2022 55.0k, Q2 2022 55.0k
30 MANNKIND CORP COM NEW MNKD MNKD 195,073 $743.0k0.17% 0.17% ReducedShares held: Q3 2021 395.1k, Q4 2021 395.1k, Q1 2022 395.1k, Q2 2022 195.1k -200.0k -200,000 -50.6%
31 VIATRIS INC COM VTRS VTRS 61,512 $644.0k0.15% 0.15% UnchangedShares held: Q3 2021 61.5k, Q4 2021 61.5k, Q1 2022 61.5k, Q2 2022 61.5k
32 NOVAVAX INC NOTE 3.750% 2/0 · principal NVAX 3.75 02.01.23 · principal NVAX 3.75 02.01.23 600,000 $600.0k0.14% 0.14% UnchangedPrincipal held: Q3 2021 600.0k, Q4 2021 600.0k, Q1 2022 600.0k, Q2 2022 600.0k
33 RLI CORP COM RLI RLI 2,400 $279.0k0.07% 0.07% UnchangedShares held: Q3 2021 2.4k, Q4 2021 2.4k, Q1 2022 2.4k, Q2 2022 2.4k